spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Bristol-Myers Squibb 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Aug 2022
Chemomab Adds Highly Experienced Executives Further Strengthening Its R&D and Clinical Capabilities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2022
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jul 2022
Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jun 2022
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Apr 2022
Halozyme Commences Tender Offer for All Outstanding Shares of Common Stock of Antares Pharma
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 13 Apr 2022
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 30 Mar 2022
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2022
Inhibrx Receives FDA Orphan-Drug Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Feb 2022
Abilita Bio Appoints Dan Bradbury to its Newly Formed Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2022
Curis Adds Three New Executives to Management Team Strengthening Medical Affairs, Clinical Development and Clinical Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Oct 2021
Inhibrx Strengthens Leadership Team with Three Key Executive Hires and Announces Appointment of Kristiina Vuori, M.D., Ph.D. to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2021
Kyverna Therapeutics Appoints Ian Clark as Chairman of the Board and Karen Walker as Chief Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jul 2021
Umoja Biopharma Expands Management Team with Key Hires in Research and Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jul 2021
Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Jun 2021
Veralox Therapeutics Appoints Michael Hanna As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jun 2021
ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE(R) drug delivery technology to enable development of "ultra-long-acting" medicines for HIV
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 17 Jun 2021
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Jun 2021
MorphImmune, Inc. Appoints Ronald Martell as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2021
IDEAYA Biosciences Appoints Susan L. Kelley, M.D., an Industry Veteran in Medical Oncology and Clinical Development, to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Jan 2021
GT Biopharma Appoints Two New Independent Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jan 2021
Veteran Biopharma Executive Dane D. Hallberg Launches MASORI Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2021
Biohaven Begins Pivotal Phase 3 Trial Of Troriluzole In Obsessive-Compulsive Disorder
Biopharmaceuticals
 HSMN NewsFeed - 17 Nov 2020
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2020
Yew Looi Liew Named President of U.S. Human Pharma for Boehringer Ingelheim Pharmaceuticals, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2020
Halozyme Announces Expansion Of Collaboration And License Agreement With argenx For ENHANZE(R) Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 5 Oct 2020
KAHR Announces Two Key Appointments to Strengthen Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Sep 2020
BioShin, Biohaven's Asia-Pacific Subsidiary, Raises $60M in Series A Funding to Advance Neuroscience Pipeline in Asia-Pacific Region
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 1 Sep 2020
Blueprint Medicines Strengthens Leadership with Appointment of Fouad Namouni, M.D., as President, Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2020
Biohaven Appoints Bob Hugin to its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 13 Apr 2020
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2020
Kleo Pharmaceuticals Elects CEO Doug Manion, MD, FCRP (C), New Chairman of the Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Feb 2020
Biohaven's Troriluzole Study For Generalized Anxiety Disorder (GAD) Misses Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 5 Feb 2020
Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Jan 2020
Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jan 2020
Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 18 Dec 2019
NeuroTrauma Sciences Appoints Dr. Todd Verdoorn as Vice President of Research and Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 2 Dec 2019
IFM Therapeutics Announces $55.5 Million Financing to Launch and Fund New Subsidiaries and Appointment of Dr. H. Martin Seidel as Chief Executive Officer
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 2 Dec 2019
Oncopeptides Appoints Joseph Horvat as President North America
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Nov 2019
Otsuka Announces Retirement of President & Chief Executive Officer William H. Carson, M.D.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2019
Halozyme Announces Actions To Focus Strategy On ENHANZE(R) Drug Delivery Technology
Biopharmaceuticals Drug Delivery Reduction in Force
 HSMN NewsFeed - 1 Oct 2019
Nektar Announces Key Executive Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Sep 2019
Artios Pharma Appoints Tania Dimitrova as Chief Business Officer and Expands Presence in the United States
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2019
Biohaven's Verdiperstat, An Oral Myeloperoxidase Inhibitor, Selected For Platform Trial Collaboration At Massachusetts General Hospital's Healey & AMG Center For Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Sep 2019
Alkermes Announces the Appointment of Richard Gaynor, M.D. and Andy Wilson to its Board of Directors and the Retirement of Director Floyd Bloom, M.D.
Biopharmaceuticals Oncology Neurology Personnel
 HSMN NewsFeed - 26 Aug 2019
Amgen To Acquire Otezla(R) For $13.4 Billion In Cash, Or Approximately $11.2 Billion Net Of Anticipated Future Cash Tax Benefits
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 20 Aug 2019
Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Aug 2019
Daiichi Sankyo, Inc. Appoints Simon King as Chief People Officer across U.S. Divisions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Aug 2019
Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo(R) (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Jul 2019
Biohaven Enrolls First Patient In Phase 3 Clinical Trial Of Verdiperstat, Oral Myeloperoxidase Inhibitor, For The Treatment Of Multiple System Atrophy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Jul 2019
Halozyme Announces Janssen Submits Extension Application To European Medicines Agency For Subcutaneous Formulation Of DARZALEX(R) Utilizing ENHANZE(R) Technology
Biopharmaceuticals Oncology Drug Delivery Regulatory
 HSMN NewsFeed - 3 Jul 2019
Caris Life Sciences Appoints Steven D. Averbuch, M.D., to Its Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2019
Halozyme Announces argenx Has Selected Second Target Under ENHANZE(R) Technology Collaboration And License Agreement
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 6 May 2019
Halozyme Names Dr. Alison A. Armour As Senior Vice President of Research and Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 May 2019
Portage Announces Change of CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2019
OncoSec Announces Advanced Therapy Medicinal Product Classification from the EMA for TAVO(TM) in Refractory Metastatic Melanoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Apr 2019
Novartis to Acquire IFM Tre to Develop First-In-Class NLRP3 Antagonist Portfolio Targeting Innate Immune System
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Feb 2019
Denovo Biopharma Announces New Hires for Positions of Chief Medical Officer of Hematology and Senior Vice President, Regulatory Affairs and Quality Assurance
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Feb 2019
SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement to Develop and Commercialize Cenobamate in Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Feb 2019
argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE(R) Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 31 Jan 2019
IGM Biosciences Appoints M. Kathleen Behrens, Ph.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jan 2019
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Jan 2019
Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Dec 2018
Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Nov 2018
Biohaven Announces FDA Acceptance of 505(b)(2) NDA Filing for BHV-0223, a Novel Sublingual Delivery Form of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology Drug Delivery FDA
 HSMN NewsFeed - 8 Nov 2018
OncoSec Appoints Robert Ward to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Nov 2018
Torque Announces Appointment of Immunotherapy Pioneer F. Stephen Hodi, MD, to Scientific Advisory Board and Alex Bruni as COO/ CFO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Oct 2018
Titan Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 17 Sep 2018
Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin(R)) In Canada
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Sep 2018
Biohaven Announces Submission of IND for BHV-3500, Third-Generation, Small Molecule CGRP-Receptor Antagonist for the Treatment of Migraine
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 12 Sep 2018
Biohaven Appoints Bob Repella to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 10 Sep 2018
Halozyme Appoints Bernadette Connaughton To Board Of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Sep 2018
Halozyme Names Benjamin Hickey As Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Aug 2018
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Aug 2018
Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Aug 2018
IGM Biosciences Appoints Julie Hambleton, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Aug 2018
Infinity Pharmaceuticals Appoints Samuel Agresta, M.D., M.P.H. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jul 2018
OncoSec Appoints Robert W. Ashworth, Ph.D. as Vice President, Regulatory
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Jul 2018
Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE(R) Technology
Biopharmaceuticals Oncology Drug Delivery
 HSMN NewsFeed - 24 Jul 2018
Biohaven Receives FDA May Proceed Letter And Initiates Phase 2/3 Clinical Trial Of Trigriluzole (BHV-4157) In Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 12 Jul 2018
Synthorx Expands Leadership Team with Three Key Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2018
FDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 28 Jun 2018
Biohaven Expands Rimegepant Development Program to Include New Prevention of Migraine Phase 3 Trial and Highlights Key Late-Breaking Presentations at American Headache Society (AHS) Annual Scientific Meeting
Biopharmaceuticals
 HSMN NewsFeed - 22 Jun 2018
Replimune Appoints Dieter K. Weinand to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Jun 2018
Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab) in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jun 2018
Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 18 May 2018
Apexigen Expands Leadership Team With Appointment Of Frances Rena Bahjat, Ph.D. Vice President, Discovery Research
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 May 2018
Aquestive Therapeutics Appoints Nancy Lurker to Board of Directors
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 24 Apr 2018
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Mar 2018
Breckenridge Pharmaceutical, Inc. Announces Final Approval of its ANDA Entecavir tablets (Baraclude(R))
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Feb 2018
Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Feb 2018
Cantel Medical Promotes Lawrence Conway to Senior Vice President, Business Systems and Integration
Devices Personnel
 HSMN NewsFeed - 1 Feb 2018
Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva(R) Tablets
Biopharmaceuticals HIV/AIDS Generics Product Launch
 HSMN NewsFeed - 18 Jan 2018
Lannett Names Timothy C. Crew To Board Of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 4 Jan 2018
Personal Genome Diagnostics Raises $75 Million to Bring Regulated IVD Genomic Tests to Cancer Patients Worldwide
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 4 Jan 2018
Enterome Raises €32 Million ($38.5 Million) in a Series D Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Jan 2018
Eiger BioPharmaceuticals Appoints David Apelian, MD, PhD, MBA Chief Operating Officer and Executive Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2018
Taiho Oncology Names Timothy Whitten President
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jan 2018
Denovo Biopharma Opens New R&D Center, Names Chief Medical Officer and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Dec 2017
Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Dec 2017
Lannett Appoints Timothy C. Crew As CEO
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 21 Dec 2017
Biohaven Enrolls First Patient In Pivotal Trial Of Trigriluzole In Patients With Obsessive-Compulsive Disorder
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Biopharmaceuticals Drug Delivery Ophthalmology Personnel
 HSMN NewsFeed - 16 Nov 2017
Biohaven Completes Enrollment In The First Of Two Pivotal Phase 3 Clinical Trials Of Rimegepant, A Second Generation Oral CGRP-Receptor Antagonist, For The Acute Treatment Of Migraine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Nov 2017
PlaqueTec Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as Chief Executive Officer
Devices Diagnostics Cardiology Personnel
 HSMN NewsFeed - 2 Oct 2017
Biohaven Reports Negative Topline Data from Spinocerebellar Ataxia (SCA) Phase 2/3 Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Sep 2017
Conventus Orthopaedics Appoints Richard Mott to its Board of Directors
Devices Orthopaedic Personnel
 HSMN NewsFeed - 26 Sep 2017
CTI BioPharma Appoints Laurent Fischer as New Chairman of the Board and Announces Management Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Sep 2017
Arvinas Appoints Dr. John Houston as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2017
Eiger Announces FDA Orphan Drug Designation Granted for Pegylated Interferon Lambda in Hepatitis Delta Virus Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Aug 2017
Mylan Advances Access in the Fight Against HIV with the Launch of Three Generic Antiretroviral Medicines in Canada
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 7 Aug 2017
BrainStorm Supports Commitment to ALS Patient Community with Appointment of a Vice President of Patient Advocacy and Government Affairs
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 4 Aug 2017
Biohaven Appoints Julia P. Gregory to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Jul 2017
Biohaven Initiates Second Pivotal Phase 3 Clinical Trial of Oral CGRP Antagonist for the Acute Treatment of Migraine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Jul 2017
Eiger Announces FDA Fast Track Designation Granted for Pegylated Interferon Lambda in Hepatitis Delta Virus Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Jul 2017
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Jul 2017
Enterome and Nestlé Health Science Launch New Diagnostics Company
Diagnostics
 HSMN NewsFeed - 6 Jul 2017
Viking Therapeutics Appoints Charles A. Rowland Jr. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jul 2017
Biohaven's BHV-5000 Receives Orphan Drug Designation from the FDA in Rett Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Jun 2017
Biohaven Broadens Senior Leadership Team With Veteran Pharma Executives
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Jun 2017
Eiger Announces Appointment of Biopharmaceutical Industry Veteran David Apelian, MD, PhD, MBA to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2017
Kleo Pharmaceuticals Inc. Appoints Douglas J. Manion M.D. as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2017
Axovant Strengthens Executive Team with Key Management Appointments
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 May 2017
Churchill Pharmaceuticals Expands Commercial Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 May 2017
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Apr 2017
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2017
CytomX Therapeutics Appoints Marion McCourt to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Mar 2017
Akcea Therapeutics Announces Three Additions to Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 20 Mar 2017
Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody(TM) Therapeutics for the Treatment of Cancer and Other Diseases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Feb 2017
BrainStorm Names Dr. June S. Almenoff and Arturo O. Araya to its Board of Directors as Company Prepares for Clinical and Commercial Success
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 24 Feb 2017
Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage(R) XR
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Feb 2017
Mitra Appoints Anton Ehrhardt as Vice President of Medical Affairs
Diagnostics Oncology Personnel
 HSMN NewsFeed - 21 Feb 2017
Bristol-Myers Squibb Appoints Three New Independent Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jan 2017
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Jan 2017
Verastem Announces Executive Leadership Appointments and Changes
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Dec 2016
ContraVir Appoints Business Development Executive Tamar Howson to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2016
Bristol-Myers Squibb and Enterome SA Announce Immuno-Oncology Collaboration Focused on Microbiome-derived Biomarkers, Drug Targets and Bioactive Molecules
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 11 Nov 2016
Bristol-Myers Squibb’s Opdivo(R) (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Nov 2016
Bristol-Myers Squibb Signs Exclusive Worldwide License Agreement with Nitto Denko for Targeted siRNA Therapy in Advanced Non-alcoholic Steatohepatitis (NASH) and Cirrhosis Due to NASH
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Nov 2016
Oncolytics Biotech(R) Inc. Announces Appointment of New Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Nov 2016
Lexicon Pharmaceuticals Acquires Exclusive Rights To Development Candidate For Neuropathic Pain From Its Alliance With Bristol-Myers Squibb
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 14 Oct 2016
Bristol-Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) for the Treatment of Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant and Treatment With Brentuximab Vedotin
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 Sep 2016
Assembly Biosciences Announces Key Additions to Microbiome Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2016
Kleo Pharmaceuticals Inc. Appoints David A. Spiegel as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2016
aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J. King, PhD, as Senior Vice President, Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Aug 2016
Derma Sciences Names Russell Olsen President of Advanced Wound Care
Regenerative Medicine Wound Care Dermatology Personnel
 HSMN NewsFeed - 8 Aug 2016
Inspyr Therapeutics Appoints Ronald Shazer, M.D., as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Jul 2016
Array BioPharma Announces Appointment Of Jason Haddock As Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Jul 2016
Janssen Announces Clinical Collaboration with Bristol-Myers Squibb to Evaluate Immuno-oncology Combination in Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Jul 2016
Advaxis Appoints Ranya Dajani as Vice President, Corporate Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Jul 2016
Bristol-Myers Squibb Acquires Cormorant Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Jun 2016
Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Apr 2016
Hematogenix Laboratory Services, LLC (Hematogenix)- Announces the Launch of two U.S. Food and Drug Administration (FDA) Approved PD-L1 Companion Diagnostic Tests to Help Guide Oncologists Using Immuno-Oncology Therapies
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 7 Apr 2016
Cipher Pharmaceuticals Proposes Adding Rosemary A. Crane and Dr. Renee P. Tannenbaum To Board of Directors
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 30 Mar 2016
Curis Announces Expansion of Executive Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Mar 2016
Tunitas Therapeutics Expands Management Team with Appointment of David J. King as Senior Vice President, Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2016
Astellas Announces Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 18 Dec 2015
Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 16 Dec 2015
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2015
Enanta Pharmaceuticals Announces the Election of Bruce L.A. Carter, Ph.D. as Non-Executive Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Nov 2015
European Commission Approves Reconciliation of Indications for nivolumab Under the Opdivo(R) European Marketing Authorization Application
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Nov 2015
Bristol-Myers Squibb Announces U.S. Food and Drug Administration Approval for Opdivo (nivolumab) as a Single Agent for the Treatment of Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Nov 2015
Akers Biosciences Appoints Medical Technology Specialist as CEO
Diagnostics Personnel
 HSMN NewsFeed - 17 Nov 2015
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 2 Nov 2015
Bristol-Myers Squibb to Acquire Cardioxyl Pharmaceuticals, Inc.
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 15 Oct 2015
Bristol-Myers Squibb Appoints Paul Biondi Senior Vice President, Head of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2015
Ovid Therapeutics Announces Appointment of Dr. Anna Kazanchyan to Senior Vice President, Business Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 Oct 2015
Bristol-Myers Squibb Receives Approval from the U.S. Food and Drug Administration for the Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen in BRAF V600 Wild-Type Unresectable or Metastatic Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Sep 2015
Brainsway Expands Management Team With Appointment of Joseph Perekupka as VP of Sales Operations, North America
Devices Neurology Personnel
 HSMN NewsFeed - 10 Sep 2015
Metamark Genetics Appoints Kenneth E. Weg as President and Chief Executive Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 27 Aug 2015
Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2015
St. Jude Medical Appoints David Dvorak to Its Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 3 Aug 2015
CytomX Announces Management Team Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 31 Jul 2015
Xencor Appoints Yujiro S. Hata to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jul 2015
European Medicines Agency Validates and Grants Accelerated Assessment of Marketing Authorization Application for Empliciti (elotuzumab) For the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Jul 2015
Baxalta Appoints Two New Directors to the Board, Further Diversifying With Strong Biopharmaceutical Leadership Experience
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2015
Celldex Therapeutics Appoints Richard Wright as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Jun 2015
Conatus Pharmaceuticals Appoints Jean L. Chan as Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2015
Bristol-Myers Squibb Receives Positive CHMP Opinion in the European Union for Opdivo (nivolumab) for the Treatment of Advanced Melanoma in Both First-Line and Previously Treated Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Apr 2015
SciFluor Life Sciences Raises $30 Million and Names William Koster, PhD, Former CEO of Neurogen Corp., as Chairman
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Apr 2015
Ovid Therapeutics Appoints Dr. Jeremy Levin as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 4 Mar 2015
Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVAC(R), a Prostate-Specific Antigen-Targeting Cancer Immunotherapy
Biopharmaceuticals Licensing Oncology
 HSMN NewsFeed - 2 Mar 2015
Mersana Raises $35 Million in Series B Financing and Appoints Anna Protopapas as President and Chief Executive Officer
Devices Drug Delivery Venture Capital Personnel
 HSMN NewsFeed - 6 Jan 2015
CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 14 Nov 2014
Bristol-Myers Squibb to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland
Biopharmaceuticals
 HSMN NewsFeed - 3 Oct 2014
Allied-Bristol Life Sciences Appoints Former Bristol-Myers Vice President Satish Jindal to Lead the Discovery of Drug Candidates From Leading Academic Institutions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2014
Cyclacel Pharmaceuticals Appoints Samuel L. Barker, Ph.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Sep 2014
Intensity Therapeutics, Inc. Appoints Ian B. Walters M.D., MBA as Vice President and Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Aug 2014
European Commission Approves Bristol-Myers Squibb’s Daklinza (daclatasvir) Across Multiple Genotypes for the Treatment of Chronic Hepatitis C Infection
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Aug 2014
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Aug 2014
Cortendo Appoints Matthew Pauls as Chief Executive Officer
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 27 Jun 2014
Bristol-Myers Squibb Receives Positive CHMP Opinion for Daklinza(R) (daclatasvir) for Treatment of Chronic Hepatitis C in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Jun 2014
Eliquis(R) (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Jun 2014
Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2014
ARIAD Announces Three Key Appointments to Its Global Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2014
Giovanni Caforio, M.D., Appointed Chief Operating Officer and Elected to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2014
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 May 2014
Bristol-Myers Squibb and CytomX Therapeutics Announce Worldwide Collaboration to Develop Probody(TM) Therapeutics Against Multiple Immuno-Oncology Targets
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 May 2014
Bristol-Myers Squibb and Incyte Enter Clinical Collaboration Agreement to Evaluate Combination Regimen of Two Novel Immunotherapies
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2014
Agios Pharmaceuticals Appoints Chris Bowden, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2014
Bristol-Myers Squibb Acquires iPierian, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Apr 2014
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2014
Tocagen Names Jamey Skillings, M.D., Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Mar 2014
Portola Pharmaceuticals Appoints John H. Johnson to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2014
Sorrento Therapeutics Appoints Mark Durand to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Mar 2014
Stem Cell Therapeutics Strengthens its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Feb 2014
In a Subanalysis, Eliquis(R) (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Feb 2014
Avillion Appoints Dr Allison Jeynes-Ellis as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Feb 2014
Ultragenyx Appoints Clay Siegall, Ph.D. and Matthew Fust to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2014
Ambrx Appoints Barry Greene to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2014
Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2014
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Jan 2014
Theravance Appoints Frank Pasqualone Senior Vice President, Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2014
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis
Biopharmaceuticals
 HSMN NewsFeed - 13 Jan 2014
U.S. FDA Approves Farxiga(TM) (Dapagliflozin) Tablets for the Treatment of Adult Patients with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 13 Jan 2014
A.P. Pharma Announces Appointment of New Directors and Effective Date of Name Change and Reverse Stock Split
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 Jan 2014
Sorrento Therapeutics Welcomes William S. Marth as Chairman of the Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jan 2014
AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Dec 2013
European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Dec 2013
ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
Devices Regenerative Medicine Endocrinology Personnel
 HSMN NewsFeed - 19 Dec 2013
Bristol-Myers Squibb Continues Evolution to Specialty BioPharma Through Sale of Its Diabetes Business
Biopharmaceuticals Endocrinology Acquisitions
 HSMN NewsFeed - 21 Nov 2013
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 6 Nov 2013
Aurinia Appoints Accomplished Biotech and Pharma Industry Veteran, Stephen W. Zaruby, as President & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2013
A.P. Pharma Makes Key Management Appointments
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 1 Nov 2013
Ferring Pharmaceuticals Appoints Alex Chang Senior Vice President, Asia Pacific
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2013
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 19 Sep 2013
Arrowhead Promotes David Lewis to Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2013
Subanalysis of Phase III ARISTOTLE Trial of Eliquis(R) (apixaban) Demonstrated Consistent Results Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation with or without Valvular Heart Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Aug 2013
Emergent BioSolutions Appoints Barry Labinger as Executive Vice President of the Company and President of Its Biosciences Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2013
MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2013
Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2013
Sialix Raises $1.0 Million in Second Round of Series B Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 26 Jul 2013
Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Jul 2013
Lantheus Medical Imaging Announces Chief Financial Officer Transition
Biopharmaceuticals Radiology Personnel
 HSMN NewsFeed - 19 Jun 2013
AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza(R) (saxagliptin)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 14 Jun 2013
Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia(R) SC (abatacept) in China
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2013
Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2013
Arcturus Therapeutics Raises $1.3 Million in Series Seed Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 May 2013
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2013
Bristol-Myers Squibb Receives US FDA sNDA Approval for Use of SUSTIVA(R) (efavirenz) in HIV-1 Infected Pediatric Patients
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 3 May 2013
Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2013
David A. Dodd Appointed President & Chief Executive Officer of Aeterna Zentaris Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Feb 2013
ARIAD Announces Appointment of European General Manager and Other Key Members of Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Feb 2013
MethylGene Announces the Appointment of Mark J. Gergen, as Executive Vice President and COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2013
The Medicines Company and Bristol-Myers Squibb Begin Global Alliance for Recothrom(R)
Biopharmaceuticals Surgery Licensing Distribution
 HSMN NewsFeed - 30 Jan 2013
Mirna Therapeutics Inc. Appoints Clay B. Siegall, Ph.D., to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Jan 2013
SciClone Announces Appointment of Simon Li to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Dec 2012
Bristol-Myers Squibb and Pfizer Announce U.S. FDA Approval of ELIQUIS(R) (apixaban)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 26 Dec 2012
ELIQUIS(R) (apixaban) Approved In Japan For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 12 Dec 2012
The Medicines Company Agrees to Acquire Incline Therapeutics, Inc.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 12 Dec 2012
The Medicines Company and Bristol-Myers Squibb Agree to Global Alliance for Recothrom(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Dec 2012
TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2012
Biota Pharmaceuticals Announces Appointment of New Executive Officers
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2012
Teva Announces Changes to Executive Leadership Team
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 22 Oct 2012
Osiris Therapeutics Names Lode Debrabandere Chief Operating Officer
Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 15 Oct 2012
Corcept Therapeutics Appoints Daniel M. Bradbury to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2012
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 4 Oct 2012
Boston Therapeutics Wins FDA Approval to File an Abbreviated New Drug Application for PAZAMET(TM) to Treat Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 3 Oct 2012
Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement
Biopharmaceuticals
 HSMN NewsFeed - 21 Sep 2012
Vanderbilt University and Bristol-Myers Squibb Sign Collaboration Agreement to Develop Novel Treatments for Parkinson’s Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Aug 2012
Polynoma Announces Appointment of New Members to Senior Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Aug 2012
Bristol-Myers Squibb Announces Successful Completion of Cash Tender Offer for Shares of Amylin Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Aug 2012
Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Jul 2012
Mevion Medical Systems Delivers the MEVION S250 Superconducting Synchrocyclotron to Robert Wood Johnson University Hospital
Devices Oncology
 HSMN NewsFeed - 10 Jul 2012
Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Jul 2012
Delcath Announced Changes To Board Of Directors
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 25 Jun 2012
Bristol-Myers Squibb and Pfizer Receive Complete Response Letter from U.S. Food and Drug Administration for ELIQUIS(R) (apixaban)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 14 Jun 2012
Cell Therapeutics Appoints New Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Jun 2012
ORENCIA(R) (abatacept) Demonstrates Comparable Efficacy to Humira(R) (adalimumab) in Patients with Moderate to Severe Rheumatoid Arthritis in First Head-to-Head Study of These Agents
Biopharmaceuticals
 HSMN NewsFeed - 25 May 2012
Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2012
Intact Vascular, LLC Hires Scott Kraus as Vice President of Sales and Marketing
Devices Interventional Personnel
 HSMN NewsFeed - 22 May 2012
AngioDynamics Completes Acquisition of Navilyst Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 16 May 2012
Insmed Appoints Donald J. Hayden, Jr. as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2012
Five Prime Therapeutics Announces the Promotion of Aron Knickerbocker to Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2012
Threshold Pharmaceuticals Appoints Robert Simon as Senior Vice President of Regulatory Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Apr 2012
Rib-X Pharmaceuticals Appoints Infectious Disease Expert and Former FDA Deputy Director Matthew Wikler, MD as Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Mar 2012
Bristol-Myers Squibb and Meso Scale Discovery Enter Agreement to Develop Diagnostic Assays for Alzheimer’s Disease
Diagnostics Neurology
 HSMN NewsFeed - 19 Mar 2012
Versant Ventures -- Leading Seed/Early Stage Healthcare Venture Capital Firm -- Appoints Dr. Guido Magni as Venture Partner
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 8 Mar 2012
S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Feb 2012
Satori Pharmaceuticals Raises $15M in New Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Feb 2012
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Feb 2012
Auxilium Announces Appointments to Enhance Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2012
ImmunoGen, Inc. Announces Addition of Kristine Peterson and Dean Mitchell to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Jan 2012
Bristol-Myers Squibb and AstraZeneca Receive Complete Response Letter from U.S. Food and Drug Administration for Dapagliflozin
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 1 Jan 2012
Teva Announces Management Succession
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2011
Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2011
S1 Pharmaceuticals Appoints Robert Taylor Segraves, MD, PhD, and Robert Pyke, MD, PhD to Its Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2011
Panmira Announces Appointment of New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Oct 2011
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Sep 2011
Bristol-Myers Squibb and Saladax Biomedical Expand Collaboration for Diagnostic Assays for Alzheimer’s Disease
Diagnostics Neurology
 HSMN NewsFeed - 15 Sep 2011
Curis, Inc. Announces Appointment of Robert Martell, M.D., Ph.D. to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2011
Bristol-Myers Squibb Completes Acquisition of Amira Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Aug 2011
Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Aug 2011
Nycomed US Inc. Names Brian A. Markison as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2011
Ramona M. Lloyd, Ph.D., RAC, Joins Omthera Pharmaceuticals as Vice President Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2011
Bristol-Myers Squibb to Acquire Amira Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Jul 2011
ZIOPHARM Oncology Appoints Hagop Youssoufian, M.Sc., M.D., as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Jul 2011
Celldex Expands Senior Management Team with Appointment of Dr. Ronald A. Pepin, Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2011
Sheila Gujrathi, M.D. Named Chief Medical Officer of Receptos
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2011
Amicus Therapeutics Announces John F. Crowley to Return as Chairman and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2011
Spectrum Pharmaceuticals Announces Promotions of Steven M. Fruchtman, MD, to Chief Medical Officer, Head of Medical & Regulatory Affairs, and Nozar Azarnia, PhD, to Head of Biostatistics and Data Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2011
Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 May 2011
Genetic Technologies Files New Patent Infringement Suit in USA
Biopharmaceuticals Diagnostics Oncology Litigation
 HSMN NewsFeed - 20 May 2011
ELIQUIS(R) (apixaban) Approved In Europe For Preventing Venous Thromboembolism After Elective Hip Or Knee Replacement
Biopharmaceuticals Surgery Orthopaedic
 HSMN NewsFeed - 3 May 2011
Optimer Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2011
Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2011
A.P. Pharma Announces Financing of Up to $4.5 Million and Names CEO and COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2011
Ligand Names Matthew W. Foehr Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2011
RXi Pharmaceuticals Aggressively Moves into Late-Stage Clinical Development with the Agreement to Acquire Apthera, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 28 Mar 2011
Janet Hammond Joins Roche as Vice President, Translational Medicine - Virology
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2011
Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Mar 2011
Synergy Pharmaceuticals Appoints Dr. Laura Barrow as Vice President of Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2011
Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint of Improvement in Overall Survival in Previously-Untreated Patients with Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2011
Lilly Announces New Vice President of Oncology Research
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Feb 2011
Allon Appoints Dr. Michael Gold Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Feb 2011
Baxter Appoints Two Corporate Officers
Devices Personnel
 HSMN NewsFeed - 11 Feb 2011
Lilly Announces Senior Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Feb 2011
FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include Data Supporting the Recommended Adult Dose of REYATAZ/ritonavir 300/100 mg for HIV-1 Infected Pregnant Women
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 2 Feb 2011
Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Feb 2011
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jan 2011
Ligand Acquires CyDex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Jan 2011
Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 19 Jan 2011
Momenta Pharmaceuticals Announces Appointment of Thomas P. Koestler to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2011
Anders Lundström to Be the New CEO of Orexo
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2011
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Jan 2011
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Dec 2010
Newly Published Investigational Apixaban ADVANCE-3 Study Results Demonstrate Statistical Superiority to Enoxaparin with Comparable Rates of Bleeding in the Prevention of Venous Thromboembolism Following Total Hip Replacement Surgery
Biopharmaceuticals Orthopaedic Surgery
 HSMN NewsFeed - 20 Dec 2010
Brian Markison to Join Rosetta Genomics Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 15 Dec 2010
Tranzyme Pharma Appoints Pharmaceutical Industry Veteran John H. Johnson as Chairman of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Dec 2010
Dr. Steve Kaldor Joins Furiex Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2010
Faheem Hasnain Named President and Chief Executive Officer of Receptos
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2010
Otsuka Prevails in U.S. Abilify(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 15 Nov 2010
Christine A. Poon Elected to Regeneron Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2010
Forest Laboratories, Inc. Announces Executive Management Promotions and Retirement of Lawrence Olanoff as President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2010
Ambit Biosciences Strengthens Board of Directors and Executive Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Nov 2010
Infinity Augments Executive Leadership Team, Appointing New Chief Medical Officer and New Vice President, Product Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Nov 2010
Ligand Announces Approval for Revolade(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Oct 2010
AVI BioPharma Announces Key Leadership Appointments to Advance Capabilities in Drug Discovery, Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Oct 2010
U.S. Food and Drug Administration Approves BARACLUDE(R) (entecavir) as a Treatment for Chronic Hepatitis B Patients with Evidence of Decompensated Liver Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Oct 2010
Exelixis Licenses Programs to Bristol-Myers Squibb Company
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Oct 2010
Bristol-Myers Squibb Completes Tender Offer for ZymoGenetics, Inc. with 94.9% of Shares Tendered
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Oct 2010
Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease
Biopharmaceuticals Neurology Personnel FDA
 HSMN NewsFeed - 15 Sep 2010
Ensemble Appoints Ted Hibben as Senior Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Sep 2010
Bristol-Myers Squibb Begins Tender Offer to Acquire ZymoGenetics, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Sep 2010
Tekmira Pharmaceuticals Strengthens Management Team With Addition of Paul Brennan as Senior Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2010
Bristol-Myers Squibb to Acquire ZymoGenetics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Aug 2010
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Aug 2010
Ipilimumab Receives FDA Priority Review Designation for Adult Patients with Previously Treated Advanced Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Jul 2010
European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Jul 2010
Lux Biosciences Names Dean Mitchell President and CEO
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 29 Jun 2010
Zymeworks Closes $3.2 Million Round of Financing and Announces the Addition of Dr. Donald Drakeman to Its Board of Directors
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 23 Jun 2010
BioElectronics Welcomes New Additions to Marketing Team
Devices Personnel
 HSMN NewsFeed - 23 Jun 2010
Spectrum Pharmaceuticals Appoints James E. Shields as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2010
Exelixis Regains Full Rights to Develop and Commercialize XL184
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2010
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Jun 2010
Tranzyme Pharma and Norgine Sign License Agreement for Late-Stage Development Product, Ulimorelin (TZP-101), in Europe and Other Select Regions
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Jun 2010
Alnylam Strengthens Management Team with New Key Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2010
Cleveland BioLabs Adds Regulatory Affairs Expertise to Development Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Apr 2010
AMAG Pharmaceuticals, Inc. Appoints Gary J. Zieziula as Executive Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Apr 2010
Aton Pharma Acquires Parkinson's Drug LODOSYN(R) (carbidopa)
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 19 Apr 2010
Mylan Announces Approval Under PEPFAR for Generic Version of Videx(R) EC HIV Treatment
Biopharmaceuticals Generics HIV/AIDS FDA
 HSMN NewsFeed - 5 Apr 2010
OXiGENE Appoints Tamar D. Howson and Peter J. Langecker to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2010
Merck Serono: Erbitux Granted Extended Use in Japan for 1st-Line Treatment of mCRC Patients with KRAS Wild-Type Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Mar 2010
ABRAXANE Meets Primary Endpoint in Phase 3 Trial for Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Mar 2010
Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53)
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 3 Mar 2010
Bristol-Myers Squibb and Allergan Enter Global Agreement on Investigational Neuropathic Pain Medicine
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 2 Mar 2010
Bristol-Myers Squibb Names Lamberto Andreotti CEO, Effective May 4; James Cornelius to Retire as CEO, Remain as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2010
FDA Advisory Committee Recommends Approval of Belatacept, an Investigational Agent for Prophylaxis of Acute Rejection in De Novo Kidney Transplant Patients
Biopharmaceuticals
 HSMN NewsFeed - 11 Feb 2010
Cadence Pharmaceuticals Receives Complete Response Letter from FDA for Intravenous Acetaminophen NDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Feb 2010
KineMed Broadens Collaboration with Bristol-Myers Squibb
Biopharmaceuticals Personalized Medicine Neurology
 HSMN NewsFeed - 3 Feb 2010
Noven Appoints Patrick Gallagher as Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2010
Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
Devices Monitoring Endocrinology Personnel
 HSMN NewsFeed - 28 Jan 2010
Abraxis BioScience Confirms Plan to Spin-off Abraxis Health in 2010 and Announces Management Structure
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jan 2010
Two Combination Treatment Regimens Added to Updated NCCN Guidelines for Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Dec 2009
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 18 Dec 2009
Ligand Announces Positive Regulatory Opinion in Europe for Revolade for Chronic Immune Thrombocytopenic Purpura
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Dec 2009
Dean Mitchell Appointed to Talecris Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2009
Bristol-Myers Squibb Announces Appointment of Charles Bancroft as Acting Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2009
Tranzyme Pharma Enters Into Strategic Drug Discovery Collaboration with Bristol-Myers Squibb
Biopharmaceuticals
 HSMN NewsFeed - 17 Nov 2009
XOMA Appoints Jim Neal Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2009
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
Biopharmaceuticals
 HSMN NewsFeed - 5 Nov 2009
NeurogesX Expands Commercial Operations Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2009
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2009
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Oct 2009
New Data Describe Safety of Subcutaneous Administration of ORENCIA(R) (abatacept) For Patients with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 16 Oct 2009
Endocyte Officials Announce Close of $26 Million Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Oct 2009
Seattle Genetics Names Head of Commercial and Announces Management Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Sep 2009
Data Presented from Two Phase 3 ERBITUX(R) Studies in First-Line Metastatic Colorectal Cancer Patients at Joint 15th European Cancer Organisation and 34th European Society for Medical Oncology Multidisciplinary Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Sep 2009
AVEO Pharmaceuticals Appoints William J. Slichenmyer, M.D., Sc.M., as Chief Medical Officer and Robert C. Young, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Sep 2009
Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2009
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 26 Aug 2009
Updated ORENCIA(R) (abatacept) Labeling Includes Data to Support Earlier Use in Adult Patients with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 25 Aug 2009
Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Aug 2009
Symphogen Appoints Adriann Sax Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2009
XDx Completes $14.4 Million Series G Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 28 Jul 2009
Bristol-Myers Squibb Begins Tender Offer to Acquire Medarex, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Jul 2009
ImClone Systems and Bristol-Myers Squibb Announce Revisions to ERBITUX(R) (cetuximab) U.S. Product Labeling for Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Jun 2009
I-Therapeutix, Inc. Closes $15 Million Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 10 Jun 2009
ZymoGenetics Appoints Eleanor L. Ramos, M.D. Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2009
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 May 2009
New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 May 2009
FDA Grants Full Approval for SPRYCEL (dasatinib) for the Treatment of Adults with Chronic Myeloid Leukemia Who Are Resistant or Intolerant to Prior Therapies Including Gleevec*
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2009
Avila Therapeutics Appoints Katrine S. Bosley as Company's First CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2009
Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 May 2009
CytRx Appoints Jaisim Shah Chief Business Officer and Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Apr 2009
Ligand Announces Approval in Europe of CONBRIZA for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Apr 2009
U.S. Food and Drug Administration Extends Review Timeline for ONGLYZA (saxagliptin) New Drug Application
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 17 Apr 2009
Lilly Names Susan Mahony Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2009
ARIAD Appoints Former Bristol-Myers Squibb Senior Executive as New Independent Member of Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2009
FABLYN Approved in Europe for the Treatment of Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Mar 2009
BG Medicine: Peter Gardiner Appointed Vice President, Medical Affairs and Senior Medical Officer
Diagnostics Personnel
 HSMN NewsFeed - 3 Mar 2009
Bristol-Myers Squibb Announces Organizational Changes; Names Four to Company's Executive Committee
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2009
Bristol-Myers Squibb Names Andreotti President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2009
ImClone Systems and Bristol-Myers Squibb Update Status of First-Line Squamous Cell Carcinoma of the Head and Neck Supplemental Biologics Application for ERBITUX(R) in U.S.
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Mar 2009
Pearl Therapeutics Appoints Perry Karsen as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2009
Sopherion Therapeutics Announces Appointment of New Senior Executive Vice President for Clinical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2009
Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2009
FDA Approves Clinical Studies of a Novel Anti-Cancer Drug Developed by Italian Researchers
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Jan 2009
ImClone Systems and Bristol-Myers Squibb Update the Status of Non-Small Cell Lung Cancer Supplemental Biologics Application Submission for ERBITUX(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Jan 2009
Howard Feldman Joins Bristol-Myers Squibb as Vice President and Therapeutic Area Head, Global Clinical Research, Neuroscience
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2009
ARIAD Expands Management Team with Executive Appointments in Regulatory Affairs, Manufacturing and Information Technology
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Dec 2008
Mylan's Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
Biopharmaceuticals Generics FDA HIV/AIDS
 HSMN NewsFeed - 12 Dec 2008
Bristol-Myers Squibb and Exelixis Enter Global Collaboration on Two Novel Cancer Programs
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Dec 2008
ERBITUX® Supplemental Biologics License Application for Advanced Non-Small Cell Lung Cancer Submitted to U.S. Food and Drug Administration
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Dec 2008
Avila Therapeutics Appoints Daniel S. Lynch as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2008
Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Nov 2008
NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Nov 2008
NCCN Updates Guidelines for Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Oct 2008
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Oct 2008
Hospitals, Healthcare Providers to Save with Premier Agreement for Cardiac Ultrasound Contrast Media
Biopharmaceuticals Radiology Group Purchasing
 HSMN NewsFeed - 22 Oct 2008
Study Published in New England Journal of Medicine Shows K-ras Gene Mutation Status May Affect Response to ERBITUX(R) Treatment
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Oct 2008
Abraxis BioScience and Specialised Therapeutics Australia Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in Australia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Oct 2008
Excaliard Pharmaceuticals Appoints Lincoln Krochmal, MD, President & Chief Executive Officer and Jeffrey Jenson, Head of Clinical Operations.
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 6 Oct 2008
ImClone Announces Merger Agreement with Eli Lilly at $70 Per Share
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Sep 2008
PDL BioPharma Names Faheem Hasnain President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2008
Bristol-Myers Squibb to Commence Cash Tender Offer for ImClone Systems at $62.00 per share
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Sep 2008
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Sep 2008
Christine A. Poon Plans Retirement from Johnson & Johnson in Early 2009
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2008
Bristol-Myers Squibb Submits Letter to ImClone Board of Directors
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Sep 2008
ImClone Systems Issues Statement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Sep 2008
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2008
Inverness Medical Launches Portable Blood Testing Monitor to Warn Patients and Their Physicians of Potential Blood Clots
Diagnostics
 HSMN NewsFeed - 3 Sep 2008
Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2008
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Sep 2008
New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 29 Aug 2008
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Aug 2008
Bristol-Myers Squibb Welcomes NICE Guidance Recommending Baraclude(R) (entecavir) as a Treatment Option for Chronic Hepatitis B
Biopharmaceuticals
 HSMN NewsFeed - 20 Aug 2008
Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Aug 2008
Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 5 Aug 2008
ISENTRESS(R) (raltegravir), Merck's First in Class Integrase Inhibitor, Reduced HIV Viral Load and Increased CD4 Cell Counts Through 96 Weeks in Treatment-Naive HIV-Infected Patients When Taken With Other Anti-HIV Medicines
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 5 Aug 2008
CASTLE Data Showed Boosted REYATAZ(R) (atazanavir sulfate) and Lopinavir/r Achieved Similar Results for Undetectable Viral Load in Treatment-Naive HIV-1 Infected Patients, Regardless of Gender
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 5 Aug 2008
Pharmacopeia Announces Further Reductions to Workforce
Biopharmaceuticals
 HSMN NewsFeed - 4 Aug 2008
ImClone Systems Issues Statement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Aug 2008
Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla(R) (Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg) in Twelve Countries
Biopharmaceuticals HIV/AIDS Distribution
 HSMN NewsFeed - 31 Jul 2008
Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Jul 2008
Oscient Pharmaceuticals Promotes Mark A. Glickman to Senior Vice President, Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jul 2008
Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) (saxagliptin) for the Treatment of Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology
 HSMN NewsFeed - 21 Jul 2008
Bristol-Myers Squibb Names Chief Procurement Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2008
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Jul 2008
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in China
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Jul 2008
Gemin X Pharmaceuticals Appoints Peter R. Dolan to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jul 2008
A.P. Pharma Appoints Ronald J. Prentki as President, Chief Executive Officer and Member of Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jul 2008
Agios Pharmaceuticals Closes $33 Million Series A Funding
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 30 Jun 2008
Tobira Therapeutics Inc. Announces Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jun 2008
Nordic Capital and Avista Capital Partners Announce Intention to Combine Unomedical with Convatec
Devices Wound Care Mergers & Acquisitions
 HSMN NewsFeed - 26 Jun 2008
Bristol-Myers Squibb Completes Tender Offer for Kosan Biosciences Incorporated
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Jun 2008
European Commission Approves REYATAZ(R) (Atazanavir Sulfate 100mg, 150mg, 200mg, 300mg), in Combination With Other Antiretroviral Medicinal Products, for use in Treatment Naïve HIV-1 Infected Adults
Biopharmaceuticals HIV/AIDS Regulatory
 HSMN NewsFeed - 18 Jun 2008
Vertex Pharmaceuticals Announces the Appointment of Freda C. Lewis-Hall, M.D., as Executive Vice President, Medicines Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2008
Three Industry Veterans Join Ascension Orthopedics
Devices Orthopaedic Personnel
 HSMN NewsFeed - 12 Jun 2008
ORENCIA(R) (abatacept) Provided an Increasing Degree of Inhibition of Structural Damage Through Three Years in Adults with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2008
Merck Serono Strengthens its Prescription Medicines Portfolio in Latin America
Biopharmaceuticals Distribution
 HSMN NewsFeed - 3 Jun 2008
Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA
Biopharmaceuticals
 HSMN NewsFeed - 31 May 2008
ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 May 2008
Bristol-Myers Squibb to Acquire Kosan Biosciences
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 May 2008
ARIAD Appoints Former Bristol-Myers Squibb Executive to Lead Corporate Legal and Compliance Functions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 May 2008
Cantel Medical Appoints New Director
Devices Personnel
 HSMN NewsFeed - 22 May 2008
Endo Pharmaceuticals Appoints Blaine T. Davis as Vice President, Investor Relations and Corporate Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2008
Ipsen: Appointment of Gerard Picot as Vice President, Global Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Proteolix Appoints Thomas Kassberg Executive Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
Neurology
 HSMN NewsFeed - 14 May 2008
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2008
ConvaTec Introduces VERSIVA(R) XC(TM) Gelling Foam Dressings to U.S.
Devices Wound Care
 HSMN NewsFeed - 13 May 2008
Bristol-Myers Squibb and KAI Pharmaceuticals Enter Global Alliance to Develop and Commercialize KAI-9803 for Cardiovascular Disease
Biopharmaceuticals
 HSMN NewsFeed - 2 May 2008
Nordic Capital Fund VII and Avista Capital Partners Agree to Acquire ConvaTec Business for approximately $4.1 Billion
Biopharmaceuticals Devices Wound Care
 HSMN NewsFeed - 2 May 2008
ConvaTec Upgrades Flexi-Seal(R) Fecal Management System to Increase Ease of Use
Devices Wound Care
 HSMN NewsFeed - 28 Apr 2008
HeartWare Appoints David R. Hathaway, M.D. Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 23 Apr 2008
Ceregene Announces Two Key Additions to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2008
Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2008
Phytomedics Inc. Appoints Dr. Laurie Smaldone Alsup, MD., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2008
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2008
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Apr 2008
ADVENTRX Appoints Vice President of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2008
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Apr 2008
Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 8 Apr 2008
Bristol-Myers Squibb and Otsuka Receive European Marketing Authorisation for ABILIFY(R) in the Treatment and Prevention of Moderate to Severe Manic Episodes in Bipolar I Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Apr 2008
Medarex Announces Ipilimumab Program Continues to Move Forward
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Mar 2008
Discovery Labs Adds Two Executives to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2008
BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
Bristol-Myers Squibb
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.